AS

Ahamadi Sultana

Active Director Director DIN 07611113
DIN 07611113 First appointment Sep 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2016
Shareholding value •••• Premium profile

About Ahamadi Sultana

Data last updated:

Ahamadi Sultana is a Director at Istos Medical Private Limited (since 2016). The company operates in Healthcare. Istos Medical Private Limited reported revenue of ₹9.84 Cr (FY 2025).

DIN 07611113
Primary Designation Director
Industry Healthcare
First Appointment 09 Sep 2016
Oldest Company Age 10 yrs
Largest company Istos Medical Private Limited · ₹9.84 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Istos Medical Private Limited U74999KA2016PTC096385
Director09 Sep 20162016₹9.84 Cr (FY 2025)Active

Board colleagues of Ahamadi Sultana

Directorship timeline

Open interactive timeline →
Istos Medical Private Limited
Premium access

Shareholding and investment profile for Ahamadi Sultana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ahamadi Sultana

Ahamadi Sultana currently holds 1 directorship: Istos Medical Private Limited (Director, since 09 Sep 2016, revenue ₹9.84 Cr (FY 2025)).

Ahamadi Sultana was first appointed on 09 Sep 2016 as Director at Istos Medical Private Limited.

The current boards of Ahamadi Sultana's companies include Naushad Ahmed Khan Rahmathulla (Istos Medical Private Limited), Tarannum Roohi (Istos Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available